Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
96.81
-4.31 (-4.26%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Dianthus Therapeutics Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Dianthus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $140.8. The average 1-year stock price forecast is 45.44% higher than the current stock price, while the lowest is $122 (+26.02%) and the highest is $200 (+106.59%).
Price Target: $140.8 (+45.44%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dianthus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 15 | 15 | 15 | 14 | 15 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 15 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $135 | Buy | Initiates | $135 | +39.45% | Sep 11, 2026 |
| Citi | Citi | Buy Initiates $156 | Buy | Initiates | $156 | +61.14% | Sep 4, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $133 | Buy | Maintains | $133 | +37.38% | Aug 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $134 | Buy | Maintains | $134 | +38.42% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
1.86M
from 2.04M
Decreased by -8.70%
Revenue Next Year
1.78M
from 1.86M
Decreased by -4.35%
EPS This Year
-3.81
from -4.20
EPS Next Year
-4.61
from -3.81
EPS and Forward PE are based on non-GAAP adjusted numbers.